Heron Therapeutics Inc (HRTX)
1.20
-0.04
(-3.23%)
USD |
NASDAQ |
Nov 15, 16:00
1.20
0.00 (0.00%)
After-Hours: 20:00
Heron Therapeutics Research and Development Expense (Quarterly): 4.465M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 4.465M |
| June 30, 2024 | 4.432M |
| March 31, 2024 | 4.608M |
| December 31, 2023 | 24.57M |
| September 30, 2023 | 9.285M |
| June 30, 2023 | 13.21M |
| March 31, 2023 | 8.836M |
| December 31, 2022 | 11.06M |
| September 30, 2022 | 25.54M |
| June 30, 2022 | 28.83M |
| March 31, 2022 | 42.07M |
| December 31, 2021 | 28.88M |
| September 30, 2021 | 28.60M |
| June 30, 2021 | 35.23M |
| March 31, 2021 | 38.12M |
| December 31, 2020 | 44.45M |
| September 30, 2020 | 49.18M |
| June 30, 2020 | 44.00M |
| March 31, 2020 | 36.89M |
| December 31, 2019 | 48.28M |
| September 30, 2019 | 34.71M |
| June 30, 2019 | 41.42M |
| March 31, 2019 | 42.97M |
| December 31, 2018 | 39.89M |
| September 30, 2018 | 30.42M |
| Date | Value |
|---|---|
| June 30, 2018 | 30.16M |
| March 31, 2018 | 39.56M |
| December 31, 2017 | 47.76M |
| September 30, 2017 | 28.84M |
| June 30, 2017 | 28.60M |
| March 31, 2017 | 33.38M |
| December 31, 2016 | 29.50M |
| September 30, 2016 | 30.24M |
| June 30, 2016 | 27.29M |
| March 31, 2016 | 16.09M |
| December 31, 2015 | 16.26M |
| September 30, 2015 | 14.24M |
| June 30, 2015 | 16.18M |
| March 31, 2015 | 14.50M |
| December 31, 2014 | 14.20M |
| September 30, 2014 | 14.73M |
| June 30, 2014 | 14.28M |
| March 31, 2014 | 11.63M |
| December 31, 2013 | 8.354M |
| September 30, 2013 | 6.216M |
| June 30, 2013 | 10.81M |
| March 31, 2013 | 7.14M |
| December 31, 2012 | 5.152M |
| September 30, 2012 | 3.626M |
| June 30, 2012 | 3.067M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
4.432M
Minimum
Jun 2024
49.18M
Maximum
Sep 2020
26.53M
Average
28.71M
Median
Research and Development Expense (Quarterly) Benchmarks
| Journey Medical Corp | 0.913M |
| NovaBay Pharmaceuticals Inc | 0.004M |
| Palatin Technologies Inc | 4.672M |
| iBio Inc | 1.14M |
| Theriva Biologics Inc | 2.953M |